Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Sportizumab -- multimodal progressive exercise over 10 weeks decreases Th17 frequency and CD49d expression on CD8+ T cells in relapsing-remitting multiple sclerosis: a randomized controlled trial [with consumer summary]
Proschinger S, Belen S, Adammek F, Schlagheck ML, Rademacher A, Schenk A, Warnke C, Bloch W, Zimmer P
Brain, Behavior, and Immunity 2024 Feb;124:397-408
clinical trial
This trial has not yet been rated.

Copyright release for this abstract has not been granted.

Abstract and full text (sometimes free) may be available at these link(s):      help